• 1
    Albert DM, Jakobiec FA. Allergic and toxic reactions. In: AlbertDM, JakobiecFA, editors. Principles and practice of ophthalmology, 1st edn. Philadelphia, PA: WB Saunders, 1994:9397.
  • 2
    Bonini S, Lambiase A, Bonini S. Genetic and environmental factors in ocular allergy. In: AbelsonMB, editor. Allergic diseases of the eye. Philadelphia, PA:W.B. Saunders, 2001:112.
  • 3
    Casey R. Atopic keratoconjunctivitis. In: AbelsonMB, editor. Allergic diseases of the eye. Philadelphia, PA: W.B. Saunders, 2001:137143.
  • 4
    Bonini S, Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow up. Ophthalmology 2000;107:11571163.
  • 5
    Leonardi A, Smith ML, Secchi GA. Vernal keratoconjunctivitis. In: AbelsonMB, editor. Allergic diseases of the eye. Philadelphia, PA: W.B. Saunders 2001:183199.
  • 6
    Dogru M, Yildiz M, Baykara M, Ozcetin H, Erturk H. Corneal sensitivity and ocular surface changes following preserved amniotic membrane transplantation for non-healing corneal ulcers. Eye 2003;17:139148.
  • 7
    Leibowitz HM, Villazon S. Corneal procedures. In: LeibowitzHM, WaringGO, editors. Corneal disorders. Philadelphia, PA: WB Saunders, 1998:983984.
  • 8
    Junko H. AD classification of fluorescein staining. In: TanoY, WatanabeN, editors. Practical ophthalmology. Tokyo, Japan: Bunkodo Publishers, 1998:61.
  • 9
    Toda I, Tsubota K. Practical double vital staining for ocular surface evaluation. Cornea 1993;12:366367.
  • 10
    Dogru M, Asano-Kato N, Tanaka M, Igarashi A, Shimmura S, Shimazaki J et al. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr Eye Res 2005;30:897908.
  • 11
    Nelson JD. Impression cytology. Cornea 1988;7:7181.
  • 12
    Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 2003;170:22742278.
  • 13
    Razzaque MS, Foster CS, Ahmed AR. Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003;44:16161621.
  • 14
    Dottorini ML, Bruni B, Peccini F, Bottini P, Pini L, Donato F et al. Skin prick-test reactivity to aeroallergens and allergic symptoms in an urban population of central Italy: a longitudinal study. Clin Exp Allergy 2007;37:188196.
  • 15
    Eriksson NE, Holmen A. Skin prick tests with standardized extracts of inhalant allergens in 7099 adult patients with asthma or rhinitis: cross-sensitizations and relationships to age, sex, month of birth and year of testing. J Investig Allergol Clin Immunol 1996;6:3646.
  • 16
    Arshad SH, Tariq SM, Matthews S, Hakim E. Sensitization to common allergens and its association with allergic disorders at age 4 years: a whole population birth cohort study. Pediatrics 2001;108:E33.
  • 17
    Leonardi A, Busca F, Motterle L, Cavarzeran F, Fregona IA, Plebani M et al. Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. Acta Ophthalmol Scand 2006;84:406410.
  • 18
    Xavier YM, Avinoam BS. Corneal hypoesthesia. Surv Ophthalmol 1988;33:2840.
  • 19
    Carlsen KH, Halvorsen R, Pettersen M, Carlsen KC. Inflammation markers and symptom activity in children with bronchial asthma. Influence of atopy and eczema. Pediatr Allergy Immunol 1997;8:112120.
  • 20
    Neal P, Barney NP. Vernal and atopic keratoconjunctivitis. In: KrachmerJH, MannisMJ, HollandEJ, editors. Cornea. Philadelphia, PA: Elsevier Mosby, 2005:667674.
  • 21
    Dogru M, Nakagawa N, Tetsumoto K, Katakami C, Yamamoto M. Ocular surface disease in atopic dermatitis. Jpn J Ophthalmol 1999;43:5357.
  • 22
    Lemp MA, Dohlman CH, Holly FJ. Corneal dessication despite normal tear volume. Ann Ophthalmol 1970;6:258284.
  • 23
    Kinoshita S, Kiorpes TC, Friend J, Thoft RA. Goblet cell density in ocular surface disease. Arch Ophthalmol 1983;101:12841287.
  • 24
    Dogru M, Okada N, Asano-kato N, Igarashi A, Fukagawa K, Shimazaki J et al. Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis. Clin Exp Allergy 2006;36:110.
  • 25
    Uchio E, Ono SY, Ikezawa Z, Ohno S. Tear levels of interferon-gamma, interleukin(IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 2000;30:103109.
  • 26
    Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997;185:885892.
  • 27
    Temann UA, Prasad B, Gallup MW, Basbaum C, Ho SB, Flavell RA et al. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol 1997;16:471478.
  • 28
    Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA, Nadel JA. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999;162:62336237.
  • 29
    Longphre M, Li D, Gallup M, Drori E, Ordonez CL, Redman T et al. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest 1999;104:13751382.
  • 30
    Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:22582261.
  • 31
    Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigen PE et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997;185:21432156.
  • 32
    Kunert KS, Keane-Myers AM, Spurr-Michaud S, Tisdale AS, Gipson IK. Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci 2001;42:24832489.
  • 33
    Ilene K, Gipson IK, Hori Y, Argueso P. Character of ocular surface mucins and their alteration in dry eye disease. The Ocular Surface 2004;2:131145.
  • 34
    Ohashi Y, Dogru M, Tsubota K. Laboratory findings in tear fluid analysis. Clin Chim Acta 2006;15:369.
  • 35
    Roat MI, Ohji M, Hunt La VE, Thoft RA. Conjunctival epithelial cell hypermitosis and goblet cell hyperplasia in atopic keratoconjunctivitis. Am J Ophthalmol 1993;116:456463.
  • 36
    Foster CS, Rice BA, Dutt JE. Immunopathology of atopic keratoconjunctivitis. Ophthalmology 1991;98:11901196.
  • 37
    Gollub EG, Waksman H, Goswami S, Marom Z. Mucin genes are regulated by estrogen and dexamethasone. Biochem Biophys Res Commun 1995;217:10061014.
  • 38
    Becquet F, Goldschild M, Moldovan MS, Ettaiche M, Gastaud P, Baudouin C. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res 1998;17:419425.
  • 39
    Tomlinson A, Trees GR. Effect of preservatives in artificial tear solutions on tear film evaporation. Ophthalmic Physiol Opt 1991;11:4852.
  • 40
    Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol 2002;120:330337.
  • 41
    Moore CP, McHugh JB, Thorne JG, Phillips TE. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model. Invest Ophthalmol Vis Sci 2001;42:653659.